Ionis Pharmaceuticals Inc (IONS)

Ionis Pharmaceuticals Inc (IONS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.3B; returns 1 day -2.2%, 1 week -0.0%, 1 year -40.0%.

Ionis Pharmaceuticals Inc. is a pioneering biotechnology company focused on discovering and developing RNA-targeted therapeutics, primarily utilizing its proprietary antisense oligonucleotide (ASO) technology, and increasingly small interfering RNA (siRNA) technology.

Groups IONS belongs to

• Shrinking Share Count
• Biotechnology
• Biopharmaceutical
• Life Sciences
• Pharmaceuticals
• Healthcare
• Rare Diseases
• Commercial Stage Biotech
• CNS Disorders
• Cardiovascular Therapies
• Neuroscience

IONS financial model: income statement, cash flow and balance sheet